September 29, 2016 5:40 AM ET

Biotechnology

Company Overview of Evelo Therapeutics, Inc.

Executive Profile

Balakrishan Gill Ph.D.

Chief Executive Officer, President and Director, Evelo Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 8 different industries.

See Board Relationships
51--

Background

Dr. Balakrishan Gill, also known as Simba, Ph.D. serves as the Chief Executive Officer of Evelo Biosciences, Inc. Dr. Gill serves as Chief Executive Officer and President of Evelo Therapeutics, Inc. He serves as the Executive Chair and Chief Executive Officer at Blackfynn Inc. He is a Senior Partner at Flagship Ventures. He joined Flagship Ventures in 2015 and focuses on providing strategic counsel and support to portfolio companies. Dr. Gill founded moksha8 Pharmaceuticals, ...

Corporate Headquarters

620 Memorial Drive
Cambridge, Massachusetts 02139

United States

Phone: 617-870-1335
Fax: --

Board Members Memberships

Chief Executive Officer, President and Director
Executive Chair and Chief Executive Officer
Chief Executive Officer and Director
2016-Present
Non-Executive Director

Education

MBA
INSEAD
PhD
King's College London

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Evelo Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.